MAPT and Mental deterioration: A previously reported absence of an association between KL-VShet and cognitive decline in asymptomatic participants with elevated levels of Aβ44 did not assess the presence of abnormal neurofibrillary tau, which may have hampered to detect an effect of KL-VShet on cognitive decline in subjects at risk of AD35.